Nearly half a century ago, omega-3 fatty acids first gained attention after scientists identified their copious presence in the fatty diet of Eskimos. Despite the increased lipid profile of their diet, they featured markedly lower serum triacylglycerol and cholesterol levels compared to their aged-matched counterparts in the developed world. Exhaustive modern day research has elucidated much on omega-3 fatty acids since these early investigations.
Omega-3 fatty acids are biochemical, oily-like molecules with highly specific structures. There are two omega-3 polyunsaturated fatty acids that are of paramount importance: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
In 2009, heart disease was identified as the leading cause of death of 1 in every 4 Americans. This dismal reality has increased clinical research across the board. EPA and DHA are today well-studied molecules principally responsible for the cardiovascular, brain, and joint supportive properties of Omega-3. These are essential biomolecules; meaning they cannot be independently synthesized de novo.
While EPA and DHA are conventionally associated with fish oil supplements, cutting-edge research indicates the modality of supplementation naturally present in krill oil supplements far supersedes conventional fish oil supplementation. Scimera BioScience has recognized the significant advantage of krill oil omega-3 fatty acids and proudly introduces SciKrill.
SciKrill oil is derived from the krill shrimp, which are small, crustacean organisms that thrive in the frigid seas of the Antarctic and singly comprise the largest biomass on the planet. Found in Antarctic krill cells are highly fluidized cell membranes attributable to complementary levels of EPA and DHA anchored in their phospholipid bilayer. This affords krill a unique ability to thrive in the glacial polar waters.
Although both krill and fish oil contain EPA and DHA, fish oil omega-3 fatty acid supplements largely exist in the form of fatty triglycerides. Krill oil omega-3 fatty acids, however, are naturally linked to phospholipids that comprise the fundamental cellular building blocks of life. This provides a more bioavailable method of omega-3 supplementation that is readily absorbed in the small intestine. This facilitates the utilization of DHA and EPA and minimizes stagnant storage in adipose tissue.
The most prevalent omega-3 fatty acid supplying phospholipid is phosphatidylcholine. Phosphatidylcholine is a preferred method of EPA and DHA administration because of its significant prevalence in highly active cell membranes. SciKrill’s more bio-recognizable form of EPA and DHA naturally promote incorporation into the dynamic membranes of the nervous and cardiovascular system.
DHA is the most common fatty acid in the brain and comprises nearly 15 percent of nervous system tissue has been evaluated in cognition, mood, and behavioral studies. Presentation of DHA attached to more bioavailable phospholipids promotes nervous system incorporation and minimizes incorporation into stagnant fatty tissue. Omega-3 fatty acids are also indicated in promoting healthy joint function.
SciKrill also contains natural levels of phosphatidylethanolamine, and phosphatidylinositol; other important nervous system phospholipids not typically found in fish oil based supplements. These molecules are supplied in natural levels by SciKrill and support healthy function throughout the body.
Additionally, SciKrill omega-3 fatty acids are interlaced with the powerful, biological antioxidant Astaxanthin. This red carotenoid is responsible for the natural red color of krill. Astaxanthin can also cross the blood-brain barrier and support nervous system structures.
Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. One serving of SciKrill provides 460mg of Omega 3 phospholipids which is among the highest in the industry.
Scimera BioScience believes that SciKrill omega-3 phospholipid supplementation will complement a healthy lifestyle and should be discussed with your physician to maximize potential benefits.